Skip to content

Service Development of POCUS in the IBD Clinic

Does the Use of Point of Care Ultrasound During Inflammatory Bowel Disease Clinic Appointments Change Management, Speed up Treatment Decisions and Save Money: a Feasibility and Service Development Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05838196
Enrollment
122
Registered
2023-05-01
Start date
2023-04-24
Completion date
2024-11-01
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Keywords

Intestinal ultrasound

Brief summary

Study to determine whether the use of an ultrasound completed during an inflammatory bowel disease (IBD) clinic will speed up diagnosis, treatment initiation, reduce complications, save money and reduce investigations compared with our current standard of care.

Detailed description

After being provided with study information and providing written informed consent, participants attending the inflammatory bowel disease clinic will be randomised to standard of care or to receiving an ultrasound during the clinic appointment. This ultrasound result will be used to determine treatment decisions. Participants will have a 6 month follow-up to capture outcome data and further medical record review will be conducted at one year.

Interventions

DIAGNOSTIC_TESTPoint-of-care ultrasound

Point-of-care ultrasound performed during clinic appointment

Sponsors

University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 16 years or above * Attending IBD clinic face-to-face * Able to give informed consent. * Belonging to one of the following groups: 1. New patients with high clinical suspicion of IBD 2. Known UC/IBD-U and possible flare 3. Known Crohn's and possible flare 4. Known IBD and assessing response to a new medication or following surgery 5. Known IBD and clinician planning endoscopic or radiological investigations

Exclusion criteria

* Inflammatory bowel disease limited to proctitis with no clinical suspicion of extension

Design outcomes

Primary

MeasureTime frameDescription
Compare time to definitive IBD-related treatment initiation with the use of POCUS compared to standard of care6 monthsTime in days for when a new medication is started, dose changed, medication stopped, or surgery performed following the clinic appointment

Secondary

MeasureTime frameDescription
Compare sensitivity and specificity of POCUS to identify active disease with standard of care investigations (MRI, ultrasound, endoscopy)6 monthsUsing formalised imaging or endoscopy as gold standard for determining disease activity, compare findings on POCUS to determine sensitivity and specificity
Compare healthcare resource utilisation including outpatient appointments, need for further investigations and admissions in patients receiving POCUS or standard of care1 yearUsing NHS cost tariffs, estimated costs for participants following standard of care to those receiving POCUS over the year following enrolment
Compare findings at POCUS when performed by a gastroenterologist or a radiologist6 monthsPOCUS will be performed by gastroenterologists or radiologist and outcomes on sensitivity/specificity will be compared between the two
Compare clinical disease activity scores when POCUS is used compared with standard of care6 monthsUsing disease activity score questionnaires (HBI (If Crohn's disease) or SCCAI (If ulcerative Colitis)) at baseline and six months.
Does point of care ultrasound change clinical decision making in the IBD clinicImmediateDoes the clinical decision made before ultrasound differ from that following ultrasound.
Compare haemaglobin levels when POCUS is used compared with standard of care6 monthsAre there significant difference between the change in haemaglobin from baseline to six months in the POCUS group compared with standard of care
Compare CRP levels when POCUS is used compared with standard of care6 monthsAre there significant difference between the change in CRP from baseline to six months in the POCUS group compared with standard of care
Compare Platelets when POCUS is used compared with standard of care6 monthsAre there significant difference between the change in platelets from baseline to six months in the POCUS group compared with standard of care
Compare use of steroids with POCUS compared with standard of care1 yearNumber of courses of steroids and total steroid dose over the duration of the trial

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026